Streetbeat News

Stock Prices

FOXO

FOXO Technologies Inc. received a notice from NYSE Regulation for noncompliance with continued listing standards due to the late filing of its Form 10-Q. The company attributes the delay to recent restructuring and asserts its commitment to regaining compliance. The notice does not immediately affect the trading of FOXO's Class A common stock on the NYSE American.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:39 pm

CAAP

Corporación América Airports (CAAP) reported a 14.5% year-over-year increase in passenger traffic for November 2023, matching the traffic levels of November 2019. All countries where CAAP operates, except Brazil and Italy, have surpassed their November 2019 passenger traffic levels.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:35 pm

AYI

Wells Fargo analyst Joseph O'Dea has maintained an Overweight rating on Acuity Brands (NYSE:AYI) and increased the price target from $200 to $236.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:34 pm

ALDX

CGEN

IFBD

Compugen announced it will receive a $10M milestone payment as its drug enters a Phase 3 trial with AstraZeneca for biliary tract cancer, causing CGEN stock to surge 240%. Infobird reported a new business cooperation in software development for IT systems, leading to a 152% increase in IFBD shares. Aldeyra Therapeutics revealed positive Phase 2 trial results for ADX-629 in treating atopic dermatitis, resulting in a 42% rise in ALDX stock.

Portfolio Pulse from ryanfaloona@benzinga.com

December 19, 2023 | 1:33 pm

GIS

General Mills, Inc. (NYSE:GIS) is anticipated to release its fiscal 2024 Q2 earnings on Dec. 20, 2023, with expected earnings of $1.16 per share and revenue of $5.35 billion. The company has a dividend yield of 3.56%, paying a quarterly dividend of 59 cents per share. To earn $500 monthly from dividends, an investment of approximately $168,636 is needed. GIS shares recently rose 1.7% to close at $66.34.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 1:32 pm

SPY

USA Building Permits for November were reported at 1.460M, slightly below the estimate of 1.470M and lower than the prior figure of 1.498M.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:30 pm

CATX

DFCO

SHFS

THAR

Insiders at four companies have recently made notable purchases of their own stock, indicating potential confidence in their companies' prospects. Tharimmune CEO Randy Milby bought 29,000 shares at $0.50 each. Perspective Therapeutics Director Lori A Woods acquired 185,200 shares at $0.27 each. SHF Holdings CEO Sundie Seefried and a Director purchased a total of 39,700 shares at around $0.96 each. Dalrada Financial CEO Brian Bonar bought 9,000 shares at $0.29 each. These transactions can be a factor for investors considering penny stocks.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 1:29 pm

RYTM

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Rhythm Pharmaceuticals (NASDAQ:RYTM) and increased the price target from $48 to $53.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:28 pm

BPMC

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Blueprint Medicines (NASDAQ:BPMC) and increased the price target from $86 to $115.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:26 pm